Skip to main content
Premium Trial:

Request an Annual Quote

Whatman in Discussions for Possible Takeover

NEW YORK (GenomeWeb News) – General Electric and Millipore are among a handful of firms that have been mentioned as bidders for UK-based life science research products firm Whatman, according to a report in today’s issue of the Financial Times.
According to the paper, investment bank Goldman Sachs, which has been appointed to oversee a sale of the company, held a second round of auctions last week. In addition to GE and Millipore, Danaher and Parker Hannifin were named as suitors as well.
In a statement issued this morning, Whatman confirmed that it has “received a number of preliminary approaches to acquire the company. The board is in discussions with third parties in relation to a possible offer for the entire share capital of Whatman.”
Whatman makes a wide variety of products that are used for life sciences research including filters, chromatography media and columns, nucleic acid and protein sample preparation products, and protein microarrays. The firm also sells diagnostic components and medical device filters.
The Financial Times said that Whatman could fetch nearly $600 million. The firm has a market capitalization of around $330 million, based on its Tuesday afternoon trading price of 250 pence.
Whatman said on Monday that it would report 2007 revenues of roughly £116 million ($229 million), flat with last year’s results.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.